Pediatric Renal Transplantation under FK-506 Immunosuppression
- 29 June 1992
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 147 (6) , 1585-1587
- https://doi.org/10.1016/s0022-5347(17)37635-8
Abstract
Renal transplantation (11 cadaveric and 1 living-related donor) was performed in 12 pediatric recipients (mean age 10.8 years) under FK-506 immunosuppression in combination with prednisone therapy. At a mean followup of 6.1 months, patient and graft survival rates were 100% and 92%, respectively. The only graft loss was due to the recurrent hemolytic uremic syndrome 4 days after transplantation. In the functioning grafts the mean serum creatinine is 1.59 ± 1.27 mg./dl. and the mean blood urea nitrogen is 36.3 ± 24.6 mg./dl. Three patients take no prednisone, 5 are receiving 0.15 to 0.25 mg./kg. per day and 3 are taking 0.35 to 0.5 mg./kg. per day.Keywords
This publication has 7 references indexed in Scilit:
- LONG-TERM PATIENT SURVIVAL IN A PEDIATRIC RENAL TRANSPLANTATION PROGRAMTransplantation, 1991
- THE USE OF CADAVER KIDNEYS FOR TRANSPLANTATION IN YOUNG CHILDRENTransplantation, 1990
- CyclosporineNew England Journal of Medicine, 1989
- A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomeraseNature, 1989
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1987